What is Acute Lymphoblastic Leukemia?

Acute lymphoblastic leukemia is a blood malignancy that develops through its rapid expansion in bone marrow. The condition develops when the bone marrow produces excessive numbers of lymphoblasts, immature white blood cells. The body faces challenges in fighting infections and delivering oxygen, and controlling bleeding because abnormal cells replace normal blood cells.

ALL is most common in children, but it can also affect teenagers and adults. Although it is an aggressive cancer, improvements in chemotherapy, targeted therapy, immunotherapy, and bone marrow transplants have greatly increased survival rates, especially for children.

Acute Lymphoblastic Leukemia can be introduced as a type of leukemia that affects lymphocytes, which are white blood cells important for the immune system.

The word “acute” means the disease progresses quickly and needs immediate treatment. “Lymphoblastic” refers to immature lymphocytes (lymphoblasts) that multiply uncontrollably in the bone marrow.

Normally, the bone marrow produces:

• Red blood cells (carry oxygen)
• White blood cells (fight infection)
• Platelets (help blood clot)

In Acute Lymphoblastic Leukemia, the bone marrow makes too many abnormal lymphoblasts, which:

• Do not fight the infection properly.
• Multiply quickly
• Replace healthy blood cells.
• Spread to the blood, lymph nodes, liver, spleen, brain, and spinal cord.

What are the main types of Acute Lymphoblastic Leukemia?

ALL is classified based on the type of lymphocyte affected:

ALL can also be classified based on genetic changes within leukemia cells. Some genetic mutations affect prognosis and treatment planning.

1. B-cell ALL: This is the most common type, especially in children.

2. T-cell ALL: This type is less common but usually grows faster. It can cause chest swelling because of enlarged lymph nodes.

Who Is at Risk by Acute Lymphoblastic Leukemia ?

Although the exact cause of ALL isn't fully known, some factors can increase the risk:

• Previous chemotherapy or radiation therapy.
• Genetic conditions such as Down syndrome
• Exposure to high levels of radiation
• Certain inherited bone marrow disorders
• Male gender (slightly higher risk)

However, many people diagnosed with ALL do not have any known risk factors.

What are the Signs & Symptoms of Acute Lymphoblastic Leukemia ?

Since ALL affects normal blood cell production, symptoms usually result from low levels of healthy blood cells. Symptoms due to low red blood cells (anemia):

• Fatigue
• Weakness
• Pale skin
• Shortness of breath

Symptoms due to low white blood cells:

• Frequent infections
• Fever
• Slow healing

Symptoms due to low platelets:

• Easy bruising
• Bleeding gums
• Nosebleeds
• Small red spots on the skin (petechiae)

Other symptoms:

• Bone or joint pain
• Swollen lymph nodes
• Enlarged liver or spleen
• Headaches or vomiting (if spread to the brain/spinal cord)
• Weight loss

Because ALL progresses quickly, symptoms can appear within a few weeks.

How Acute Lymphoblastic Leukemia Tested & Diagnosed?

Can Acute Lymphoblastic Leukemia be diagnosed?

Prompt and correct diagnosis is important because timely therapy is required.

Physical Exam

Doctors look for signs such as swollen lymph nodes, paleness, and an enlarged liver or spleen.

Blood Tests

A complete blood count (CBC) may show:

• High or low white blood cell count
• Low red blood cells
• Low platelets
• Presence of abnormal cells

Bone Marrow Aspiration & Biopsy

The most important diagnostic test is this one. A bone marrow sample is typically obtained from the hip bone to verify leukemia cell proliferation.

Using immunophenotypes

This test helps identify whether the leukemia cells are of the T-cell or B-cell lineage.

Cytogenetic & Molecular Testing

These tests help identify specific genetic abnormalities that affect treatment strategies.

Lumbar Puncture (Spinal Tap)

This checks whether leukemia has spread to the central nervous system.

What are tha Stages of Acute Lymphoblastic Leukemia ?

Unlike many solid tumors, ALL isn't staged with the usual TNM system. Instead, it's classified based on:

• Age at diagnosis
• White blood cell count at presentation.
• Genetic mutations
• Response to initial treatment
• Presence of leukemia in the brain/spinal cord

Patients are categorized into:

• Standard-risk
• High-risk
• Very high-risk

This risk stratification helps guide treatment intensity.

How Is Acute Lymphoblastic Leukemia Treated?

Since ALL is a blood cancer, surgery isn’t part of the treatment. The main treatments are chemotherapy, targeted therapy, immunotherapy, and bone marrow transplant.

Treatment typically occurs in phases.

Chemotherapy

It is the cornerstone of ALL therapy. It involves the use of strong drugs that kill cells undergoing rapid division, specifically leukemia cells.

Phases of treatment include:

a) Induction therapy

• It aims to achieve remission, in which leukemia is no longer present.
• It takes approximately 4-6 weeks.

b) Consolidation (Intensification) Therapy

• The main target/goal is to kill any remaining leukemia cells.
• This phase helps prevent relapse.

c) Intervention Therapy

• Low-dose chemotherapy is given for 2-3 years to keep leukemia from returning.

Chemotherapy may be given:

• Intravenously
• Orally
• Directly into the spinal fluid (intrathecal chemotherapy)

Targeted Therapy

Targeted therapy attacks specific genetic abnormalities in leukemia cells.

For example:

• Patients with the Philadelphia chromosome should take tyrosine kinase inhibitors (TKIs).
• These drugs target cancer cells more precisely than traditional chemotherapy and usually have fewer side effects.

Immunotherapy

Immunotherapy helps the body recognize and destroy leukemia cells.

Possible treatments are:

• Monoclonal antibodies
• Chimeric Antigen Receptor T-cell therapy
• T-cell bispecific agents

Chimeric Antigen Receptor T-cell therapy has produced positive outcomes in cases of relapsed or refractory ALL.

Radiation Therapy

Radiation is not commonly used, but may be recommended if:

• Leukemia spreads to the brain.
• There is testicular involvement.
• Before a bone marrow transplant

Bone Marrow Transplant (Hematopoietic Stem Cell Transplant)

A bone marrow transplant replaces diseased bone marrow with healthy stem cells.

It is recommended for:

• High-risk patients
• Relapsed ALL
• Poor response to chemotherapy

This treatment can lead to long-term remission but comes with serious risks and needs expert care.

Treatment for ALL is intensive and may cause:

• Hair loss
• Nausea and vomiting
• Mouth sores
• Fatigue
• Increased infection risk
• Bleeding
• Fertility issues
• Organ toxicity

Long-term follow-up is important to monitor for late treatment effects.

What is the prognosis and survival rate for Acute Lymphoblastic Leukemia?

Survival rates for ALL have improved significantly over the past few decades.

• Children: Cure rates exceed 85-90%.
• Adults: Survival rates vary between 40-70%, depending on risk factors.

Early diagnosis, genetic factors, and access to advanced treatments all play a big role in outcomes.

Currently, there is no known way to prevent ALL. However:

• Avoiding unnecessary radiation exposure
• Early medical evaluation for persistent symptoms
• Genetic counseling in high-risk families

It may help catch it early.

What supportive care services are essential while living with Acute Lymphoblastic Leukemia?

Being diagnosed with ALL can be highly stressful. The patients and their relatives are stressed, scared, and apprehensive.

Supportive Care

Supportive care includes:

• Nutritional support;
• Counseling;
• Infection prevention;
• Rehabilitation programs; and
• Programs for survivors.

Follow-up visits will be scheduled regularly to assess remission or relapse of the condition.

Why choose Tender Palm Hospital for Acute Lymphoblastic Leukemia treatment in Lucknow, India?

Tender Palm Super-Speciality Hospital offers advanced Acute Lymphoblastic Leukemia treatment in Lucknow, India, at an affordable cost. We have a team of experienced oncology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including chemotherapy, targeted therapy, and bone marrow transplantation procedures. Our Hematology and Oncology team has decades of experience in successfully treating Acute Lymphoblastic Leukemia in Lucknow, India.

To seek an Expert consultation for Acute Lymphoblastic Leukemia Treatment in Lucknow, India:

Call us at +91-9076972161
Email at care@tenderpalm.com

Request a Call Back